Orphazyme Capital Markets Day 2018 – from Biology to Bedside

Orphazyme Capital Markets Day 2018 – from Biology to Bedside

Copenhagen, May 29, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, announces that a Capital Markets Day will take place today. The Capital Markets Day will be hosted by Chief Executive Officer, Anders